U.S. officials granted full approval to a closely watched Alzheimer's drug on Thursday, clearing the way for Medicare and other insurance plans to begin covering the treatment for people with the brain-robbing disease.
from CBC | Health News https://ift.tt/kTMoVUs
Aucun commentaire:
Enregistrer un commentaire